1 Pandolfino J, "Use and utility of the bravo pH capsule" 42 : 571-578, 2008
2 Chey WD, "Treatment patterns and symptom control in patients with GERD: US community-based survey" 25 : 1869-1878, 2009
3 Kondo T, "The role of esophageal hypersensitivity in functional heartburn" 51 : 571-578, 2017
4 서검석, "The Prevalence of Erosive Esophagitis Is Not Significantly Increased in a Healthy Korean Population - Could It Be Explained?: A Multi-center Prospective Study" 대한소화기 기능성질환∙운동학회 19 (19): 70-77, 2013
5 Hidekazu Suzuki, "The Application of the Rome IV Criteria to Functional Esophagogastroduodenal Disorders in Asia" 대한소화기 기능성질환∙운동학회 23 (23): 325-333, 2017
6 Inadomi JM, "Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs" 98 : 1940-1944, 2003
7 Hershcovici T, "Step-by-step management of refractory gastresophageal reflux disease" 26 : 27-36, 2013
8 Kahrilas PJ, "Review article: oesophageal pH monitoring--technologies, interpretation and correlation with clinical outcomes" 22 (22): 2-9, 2005
9 Hirano I, "Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--bilitec, intraluminal impedance and bravo capsule pH monitoring" 23 (23): 12-24, 2006
10 Wilson JA, "New esophageal function testing (impedance, bravo pH monitoring, and high-resolution manometry): clinical relevance" 10 : 222-230, 2008
1 Pandolfino J, "Use and utility of the bravo pH capsule" 42 : 571-578, 2008
2 Chey WD, "Treatment patterns and symptom control in patients with GERD: US community-based survey" 25 : 1869-1878, 2009
3 Kondo T, "The role of esophageal hypersensitivity in functional heartburn" 51 : 571-578, 2017
4 서검석, "The Prevalence of Erosive Esophagitis Is Not Significantly Increased in a Healthy Korean Population - Could It Be Explained?: A Multi-center Prospective Study" 대한소화기 기능성질환∙운동학회 19 (19): 70-77, 2013
5 Hidekazu Suzuki, "The Application of the Rome IV Criteria to Functional Esophagogastroduodenal Disorders in Asia" 대한소화기 기능성질환∙운동학회 23 (23): 325-333, 2017
6 Inadomi JM, "Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs" 98 : 1940-1944, 2003
7 Hershcovici T, "Step-by-step management of refractory gastresophageal reflux disease" 26 : 27-36, 2013
8 Kahrilas PJ, "Review article: oesophageal pH monitoring--technologies, interpretation and correlation with clinical outcomes" 22 (22): 2-9, 2005
9 Hirano I, "Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--bilitec, intraluminal impedance and bravo capsule pH monitoring" 23 (23): 12-24, 2006
10 Wilson JA, "New esophageal function testing (impedance, bravo pH monitoring, and high-resolution manometry): clinical relevance" 10 : 222-230, 2008
11 Frazzoni M, "Impedance-pH monitoring for diagnosis of reflux disease:new perspectives" 62 : 1881-1889, 2017
12 Drossman DA, "Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV" 2016
13 Iwakiri K, "Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015" 51 : 751-767, 2016
14 de Bortoli N, "Esophageal testing: What we have so far" 7 : 72-85, 2016
15 Dent J, "Epidemiology of gastro-oesophageal reflux disease: a systematic review" 54 : 710-717, 2005
16 정혜경, "Epidemiology of Gastroesophageal Reflux Disease in Asia: A Systematic Review" 대한소화기 기능성질환∙운동학회 17 (17): 14-27, 2011
17 Dean BB, "Effectiveness of proton pump inhibitors in nonerosive reflux disease" 2 : 656-664, 2004
18 Giacchino M, "Distinction between patients with non-erosive reflux disease and functional heartburn" 26 : 283-289, 2013
19 Sofi AA, "Comparison of esophageal placement of bravo capsule system under direct endoscopic guidance with conventional placement method" 3 : 147-151, 2010
20 Pandolfino JE, "Bravo capsule pH monitoring" 100 : 8-10, 2005
국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
KISS
